Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma in vitro and in vivo.

MLA

Hu, Chuanzhen, et al. “Antitumor Effect of Focal Adhesion Kinase Inhibitor PF562271 against Human Osteosarcoma in Vitro and in Vivo.” Cancer Science, vol. 108, no. 7, July 2017, pp. 1347–56. EBSCOhost, https://doi.org/10.1111/cas.13256.

APA

Hu, C., Chen, X., Wen, J., Gong, L., Liu, Z., Wang, J., Liang, J., Hu, F., Zhou, Q., Wei, L., Shen, Y., & Zhang, W. (2017). Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma in vitro and in vivo. Cancer Science, 108(7), 1347–1356. https://doi.org/10.1111/cas.13256

Chicago

Hu, Chuanzhen, Xu Chen, Junxiang Wen, Liangzhi Gong, Zhuochao Liu, Jun Wang, Jing Liang, et al. 2017. “Antitumor Effect of Focal Adhesion Kinase Inhibitor PF562271 against Human Osteosarcoma in Vitro and in Vivo.” Cancer Science 108 (7): 1347–56. doi:10.1111/cas.13256.